Rapport Therapeutics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 20, 2026, 6:05 a.m. ETView on SEC.gov
Regulation FD disclosure · Other events · Financial statements and exhibits
AI summary, unreviewedRapport Therapeutics Reports Positive Phase 2 Bipolar Mania Results for RAP-219, Meeting Primary Endpoint at 3.1-Point YMRS Improvement (p=0.045)
8-KAug. 5, 2026, 7:17 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits